Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter

Roberto Negro, Simonetta Piana, Marisa Ferrari, Moira Ragazzi, Giorgio Gardini, Sofia Asioli, Donatella Pacchioni, Fabrizio Riganti, Roberto Valcavi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: In cases of multinodular goiter with negative cytologic result, reasonable management options include surgical treatment, simple follow-up, or more recently introduced conservative therapies such as laser or radiofrequency ablation, and recombinant human thyroid-stimulating hormone-augmented radioiodine. For patients who are eligible for follow-up or nonsurgical treatments. The possibility that they may have an undiagnosed malignancy (false-negative [FN]-fine-needle aspiration cytology [FNAC] result or incidental thyroid cancer [ITC]) should be considered. The aim of our study was to asses. The risk of malignancy in patients known to have presumably benign thyroid disease.Methods: Surgical series of patients who underwent total thyroidectomy for benign disease between 2000 and 2010 at two Italian centers were reviewed. Patients with any preoperative suspicion of malignancy were excluded.Results: Histologic examination revealed that 84 of 970 (8.6%) thyroidectomized patients had malignancy (5% ITC and 3.6% FN-FNAC), with 89.8% of ITCs having a diameter 30 mm. Sixty-seven thyroid malignancy patients (79.8%) had stage I disease (American Joint Committee on Cancer criteria). The risk of FN-FNAC increases with increasing size o. The nodule, whil. The risk of ITC increases as nodule size decreases.Conclusion: The risk of malignancy in presumably benign thyroid disease cannot be overlooked, but can be minimized through skillfully performed ultrasonography (US) examination and FNAC. Once a patient with multinodular goiter is referred for follow-up or nonsurgical therapy, careful US surveillance is mandatory.

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalEndocrine Practice
Volume19
Issue number3
DOIs
Publication statusPublished - May 1 2013

Fingerprint

Nodular Goiter
Fine Needle Biopsy
Cell Biology
Thyroid Neoplasms
Neoplasms
Thyroid Diseases
Goiter
Ultrasonography
Equidae
Joint Diseases
Thyroidectomy
Thyrotropin
Thyroid Gland
Lasers
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter. / Negro, Roberto; Piana, Simonetta; Ferrari, Marisa; Ragazzi, Moira; Gardini, Giorgio; Asioli, Sofia; Pacchioni, Donatella; Riganti, Fabrizio; Valcavi, Roberto.

In: Endocrine Practice, Vol. 19, No. 3, 01.05.2013, p. 444-450.

Research output: Contribution to journalArticle

Negro, R, Piana, S, Ferrari, M, Ragazzi, M, Gardini, G, Asioli, S, Pacchioni, D, Riganti, F & Valcavi, R 2013, 'Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter', Endocrine Practice, vol. 19, no. 3, pp. 444-450. https://doi.org/10.4158/EP12271.OR
Negro, Roberto ; Piana, Simonetta ; Ferrari, Marisa ; Ragazzi, Moira ; Gardini, Giorgio ; Asioli, Sofia ; Pacchioni, Donatella ; Riganti, Fabrizio ; Valcavi, Roberto. / Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter. In: Endocrine Practice. 2013 ; Vol. 19, No. 3. pp. 444-450.
@article{b6e99378eccc472398334b7807f0c853,
title = "Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter",
abstract = "Objective: In cases of multinodular goiter with negative cytologic result, reasonable management options include surgical treatment, simple follow-up, or more recently introduced conservative therapies such as laser or radiofrequency ablation, and recombinant human thyroid-stimulating hormone-augmented radioiodine. For patients who are eligible for follow-up or nonsurgical treatments. The possibility that they may have an undiagnosed malignancy (false-negative [FN]-fine-needle aspiration cytology [FNAC] result or incidental thyroid cancer [ITC]) should be considered. The aim of our study was to asses. The risk of malignancy in patients known to have presumably benign thyroid disease.Methods: Surgical series of patients who underwent total thyroidectomy for benign disease between 2000 and 2010 at two Italian centers were reviewed. Patients with any preoperative suspicion of malignancy were excluded.Results: Histologic examination revealed that 84 of 970 (8.6{\%}) thyroidectomized patients had malignancy (5{\%} ITC and 3.6{\%} FN-FNAC), with 89.8{\%} of ITCs having a diameter 30 mm. Sixty-seven thyroid malignancy patients (79.8{\%}) had stage I disease (American Joint Committee on Cancer criteria). The risk of FN-FNAC increases with increasing size o. The nodule, whil. The risk of ITC increases as nodule size decreases.Conclusion: The risk of malignancy in presumably benign thyroid disease cannot be overlooked, but can be minimized through skillfully performed ultrasonography (US) examination and FNAC. Once a patient with multinodular goiter is referred for follow-up or nonsurgical therapy, careful US surveillance is mandatory.",
author = "Roberto Negro and Simonetta Piana and Marisa Ferrari and Moira Ragazzi and Giorgio Gardini and Sofia Asioli and Donatella Pacchioni and Fabrizio Riganti and Roberto Valcavi",
year = "2013",
month = "5",
day = "1",
doi = "10.4158/EP12271.OR",
language = "English",
volume = "19",
pages = "444--450",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "3",

}

TY - JOUR

T1 - Assessin. The risk of false-negative fine-needle aspiration cytology and of incidental cancer in nodular goiter

AU - Negro, Roberto

AU - Piana, Simonetta

AU - Ferrari, Marisa

AU - Ragazzi, Moira

AU - Gardini, Giorgio

AU - Asioli, Sofia

AU - Pacchioni, Donatella

AU - Riganti, Fabrizio

AU - Valcavi, Roberto

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Objective: In cases of multinodular goiter with negative cytologic result, reasonable management options include surgical treatment, simple follow-up, or more recently introduced conservative therapies such as laser or radiofrequency ablation, and recombinant human thyroid-stimulating hormone-augmented radioiodine. For patients who are eligible for follow-up or nonsurgical treatments. The possibility that they may have an undiagnosed malignancy (false-negative [FN]-fine-needle aspiration cytology [FNAC] result or incidental thyroid cancer [ITC]) should be considered. The aim of our study was to asses. The risk of malignancy in patients known to have presumably benign thyroid disease.Methods: Surgical series of patients who underwent total thyroidectomy for benign disease between 2000 and 2010 at two Italian centers were reviewed. Patients with any preoperative suspicion of malignancy were excluded.Results: Histologic examination revealed that 84 of 970 (8.6%) thyroidectomized patients had malignancy (5% ITC and 3.6% FN-FNAC), with 89.8% of ITCs having a diameter 30 mm. Sixty-seven thyroid malignancy patients (79.8%) had stage I disease (American Joint Committee on Cancer criteria). The risk of FN-FNAC increases with increasing size o. The nodule, whil. The risk of ITC increases as nodule size decreases.Conclusion: The risk of malignancy in presumably benign thyroid disease cannot be overlooked, but can be minimized through skillfully performed ultrasonography (US) examination and FNAC. Once a patient with multinodular goiter is referred for follow-up or nonsurgical therapy, careful US surveillance is mandatory.

AB - Objective: In cases of multinodular goiter with negative cytologic result, reasonable management options include surgical treatment, simple follow-up, or more recently introduced conservative therapies such as laser or radiofrequency ablation, and recombinant human thyroid-stimulating hormone-augmented radioiodine. For patients who are eligible for follow-up or nonsurgical treatments. The possibility that they may have an undiagnosed malignancy (false-negative [FN]-fine-needle aspiration cytology [FNAC] result or incidental thyroid cancer [ITC]) should be considered. The aim of our study was to asses. The risk of malignancy in patients known to have presumably benign thyroid disease.Methods: Surgical series of patients who underwent total thyroidectomy for benign disease between 2000 and 2010 at two Italian centers were reviewed. Patients with any preoperative suspicion of malignancy were excluded.Results: Histologic examination revealed that 84 of 970 (8.6%) thyroidectomized patients had malignancy (5% ITC and 3.6% FN-FNAC), with 89.8% of ITCs having a diameter 30 mm. Sixty-seven thyroid malignancy patients (79.8%) had stage I disease (American Joint Committee on Cancer criteria). The risk of FN-FNAC increases with increasing size o. The nodule, whil. The risk of ITC increases as nodule size decreases.Conclusion: The risk of malignancy in presumably benign thyroid disease cannot be overlooked, but can be minimized through skillfully performed ultrasonography (US) examination and FNAC. Once a patient with multinodular goiter is referred for follow-up or nonsurgical therapy, careful US surveillance is mandatory.

UR - http://www.scopus.com/inward/record.url?scp=84880095635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880095635&partnerID=8YFLogxK

U2 - 10.4158/EP12271.OR

DO - 10.4158/EP12271.OR

M3 - Article

C2 - 23337148

AN - SCOPUS:84880095635

VL - 19

SP - 444

EP - 450

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 3

ER -